AI assistant
UroGen Pharma Ltd. — Director's Dealing 2019
Jan 10, 2019
32312_dirs_2019-01-10_7735120d-6ee4-4f82-91c5-5c554a3cba68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2019-01-01
Reporting Person: Nussbaum Ran (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 968525 | Indirect |
| Ordinary Shares | 452162 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $5.00 | 2021-07-27 | Ordinary Shares (2211) | Indirect | |
| Stock Option (right to buy) | $5.00 | 2022-09-01 | Ordinary Shares (2211) | Indirect | |
| Stock Option (right to buy) | $5.94 | 2022-12-27 | Ordinary Shares (32723) | Indirect | |
| Stock Option (right to buy) | $59.23 | 2028-06-04 | Ordinary Shares (6817) | Indirect | |
| Stock Option (right to buy) | $5.00 | 2021-07-27 | Ordinary Shares (1030) | Indirect | |
| Stock Option (right to buy) | $5.00 | 2022-09-01 | Ordinary Shares (1030) | Indirect | |
| Stock Option (right to buy) | $5.94 | 2022-12-27 | Ordinary Shares (15276) | Indirect | |
| Stock Option (right to buy) | $59.23 | 2028-06-04 | Ordinary Shares (3183) | Indirect |
Footnotes
F1: The reportable securities are owned by Pontifax (Israel) III Limited Partnership ("Pontifax Israel") . The Reporting Person is a director of Pontifax Israel.
F2: The reportable securities are owned by Pontifax Cayman III Limited Partnership ("Pontifax Cayman") . The Reporting Person is a director of Pontifax Cayman.
F3: Fully vested.
F4: 33.33% of the shares underlying the stock option vested on each of December 27, 2016, December 27, 2017 and December 27, 2018.
F5: 25% of the shares underlying the stock option vested on each of September 4, 2018 and December 4, 2018 and the remaining shares will vest 25% on each of March 4, 2019 and June 4, 2019.